Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • This company will be of major interest to investors in search of a high dividend stock.
Weaknesses
  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The group usually releases earnings worse than estimated.
  • The company's enterprise value to sales, at 3.65 times its current sales, is high.
  • For the past seven days, analysts have been lowering their EPS expectations for the company.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ROCHE HOLDING LTD.-5.60%200 973
JOHNSON & JOHNSON-9.87%337 763
PFIZER3.62%219 534
NOVARTIS-3.93%201 464
MERCK AND COMPANY11.76%169 193
AMGEN12.66%129 635
ABBOTT LABORATORIES10.50%110 556
SANOFI0.08%104 948
GLAXOSMITHKLINE19.17%103 431
BAYER-8.75%101 760
ELI LILLY AND COMPANY6.22%97 374
NOVO NORDISK A/S-5.31%94 989
BRISTOL-MYERS SQUIBB COMPAN..-7.21%92 940
ASTRAZENECA7.44%92 021
CELGENE CORPORATION-17.89%62 110
ALLERGAN PLC8.30%60 065
More Results
Financials ( CHF)
Sales 2018 55 504 M
EBIT 2018 18 485 M
Net income 2018 11 847 M
Debt 2018 4 023 M
Yield 2018 3,70%
P/E ratio 2018 16,31
P/E ratio 2019 15,81
EV / Sales 2018 3,70x
EV / Sales 2019 3,53x
Capitalization 201 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ROCHE HOLDING LTD.
Duration : Period : Day
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Duration : Period : Week
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders